Science Market Update

UC San Diego Receives Two, $2M Research Grants from CIRM

Posted by Rebecca Partridge on Mon, Feb 20, 2017

 

The California Institute for Regenerative Medicine (CIRM) awarded two scientists at UC San Diego $2 million each for their innovative research. The first award went to Alysson R. Muotri, PhD, professor in the UC San Diego School of Medicine departments of Pediatrics and Cellular and Molecular Medicine. The funding will support studies of new treatments for Zika. The second award went to Dan Kaufman, MD, PhD, professor of medicine in the Division of Regenerative Medicine. This funding will support the creation an “off-the-shelf immunotherapy” using NK cells to treat refractory or resistant tumors, such as ovarian cancer.

Read More

Tags: Bioresearch funding, Cancer Treatment, Cancer, Biotechnology Vendor Fair, UCSD, UC San Diego, CIRM, research grants, zika, Biotechnology trade show

UCR Life Science Study Uncovers Fruit Fly Metamorphosis Trigger

Posted by BCI Staff on Fri, Jan 27, 2017

Next week PLOS journal will publish an exciting article featuring a new biological discovery. Scientists at UC Riverside have discovered critical information regarding insect development.

This study uncovers the use of DNA as an organism’s biological clock in sexual development, or metamorphosis in insects. With applications in new cancer treatments, agriculture, human health and potential applications in zoology, this study opens gateways of undiscovered information. This is one exciting example of the potential in research and the intersectionality in life science, molecular biology and biotechnology supplies.


Read More

Tags: CA, agriculture, DNA Research, Cancer, Genome, UCR, Fruit Fly

Texas Medical Center Pioneers New Brain Cancer Treatment

Posted by Rebecca Partridge on Wed, Jan 18, 2017

Researchers at Texas Medical Center’s (TCM) Houston Methodist Hospital have invented a way to overcome chemotherapy drug resistance and destroy the deadliest type of brain tumors without destroying the surrounding tissue. This targeted approach combines a “smart drug” with chemotherapy. In animal models of human brain cancer, this smart drug prolonged life by over six fold.

Read More

Tags: cancer research, Texas Medical Center, Cancer, tmc, Biotechnology Vendor Fair, cancer therapy, Bioresearch Grant, Biotechnology trade show

UC Davis Inhales $2.3M in Grants for Pulmonary Bioresearch

Posted by BCI Staff on Tue, Oct 18, 2016

 (Article posted 2015 and updated in 2016)

Patients with a condition known as lung nodules may soon be breathing a bit more easily, thanks to research funding granted to the University of California, Davis  and a new diagnostic technology tested in a 2016 study at the Morehouse School of Medicine and Emory University. Lung nodules are usually benign, small lesions often found in CT chest scans. While only 2% of these nodules end up being cancerous, they still require examination and monitoring to ensure the safety of the patient. 

Read More

Tags: CA, Emory University, University of California Davis, cancer research, California, Cancer, UCDMC, BioResearch Product Faire Event, Research Funding, Sacramento, Davis, UC Davis - Medical Center, research grants, lung cancer

UC Davis Receives Over $3M in Cancer Research Funding

Posted by Rebecca Partridge on Mon, Oct 17, 2016

UC Davis Professor Kit Lam has been awarded two separate federal grants to further his cancer research. The first grant is from the National Institute of Biomedical Imaging and Bioengineering. This 4-year, $2 million grant will fund research on the use of targeted nanotheraputics against oral cancer. The second grant is from the National Cancer Institute. This 3-year, $1.2 million research grant will be used to explore new technology for functional imaging in living cells.

Read More

Tags: cancer research, California, Cancer, UCDMC, Research Funding, UC Davis - Medical Center, Southwest Region, research grants, UC Davis, UCD, cancer research grant

Breast Cancer Research Breakthrough at UI Urbana-Champaign

Posted by Rebecca Partridge on Wed, Oct 12, 2016

According to the American Cancer Society, 1 in 8 American women will develop invasive breast cancer in their lifetime, and each year over 40,000 women die from it. However, thanks to research conducted at the University of Illinois Urbana-Champaign, the number of deaths due to breast cancer may soon be significantly reduced. 

Read More

Tags: breast cancer research, University of Illinois Urbana-Champaign, cancer research, Cancer Treatment, Cancer, UI Urbana, Midwest Region, UIUC, cancer therapy

UCLA Researchers: New Evidence for Novel Method of Cancer Metastasis

Posted by Greg Paul on Fri, Aug 26, 2016

Researchers from UCLA and partnering schools guided by Laurent Bentolila found evidence supporting the spread of malignant cells through angiotropism with vascular co-option, and even suggested they may be related or identical processes.  These findings were published in Nature Scientific Reports. With angiotropism being the ability for cells to travel along surface of blood vessels, but not be inside of them, also called extravascular migratory metastasis (EVMM) and vascular co-option being the ability for a tumor to use a blood supply and travel along it, this means cancer has an outlet to spread outside of the bloodstream.  The spread outside of the bloodstream means some current methods of treating cancer would be ineffective.

“... if the metastasizing cells are on the outside of the blood vessels, they escape exposure to the treatment and continue to spread cancer.”

-Laurent A. Bentolila

Read More

Tags: CA, University of California Los Angeles, cancer research, Los Angeles, Cancer, LAVS, UCLA, laboratory, lab products, 2016

OSU Researcher Creates Home Based Test Strips for Cancer and Malaria

Posted by Rebecca Partridge on Mon, Jul 25, 2016

(Image courtesy of Wikimedia Commons

Dr. Abraham Badu-Tawiah, assistant professor at Ohio State University, is out to revolutionize the world of diagnostic testing. By making paper strips that can detect malaria and well as certain types of cancers, he hopes to make testing more practical and affordable. People would be able to simply apply a drop of blood to the paper test strip at home, much like diabetics do when testing their blood sugar, and then mail it to the laboratory. This new method would make medical diagnostics much more accessible for those who can't easily get to a lab for testing.

Read More

Tags: Midwest, Ohio State University, Ohio, Cancer, malaria, biotech vendor show, Columbus, Dr. Abraham Badu-Tawiah

$29M Core Grant Awarded to Alabama for Cancer Research Center

Posted by Rebecca Partridge on Wed, Jun 29, 2016

(Image courtesy of Wikimedia commons)

University of Alabama at Birmingham received a $29 million grant from the National Cancer Institute. This five year core grant will support six research programs at the UAB Comprehensive Cancer Center. The renewal of the Cancer Center Support Grant, the most prestigious federal grant that a cancer research and treatment program can earn, also extends UAB’s elite “comprehensive” designation. According to the UAB News website this designation is awarded for scientific excellence and the ability to integrate diverse research approaches in the fight against cancer.

Read More

Tags: Bioresearch funding, cancer research, Alabama, University of Alabama, Cancer Treatment, Cancer, University of Alabama Birmingham, UAlab, UAB, University of Alabama at Birmingham, Cancer Center, cancer researchers, fight cancer, 2016, cancer reserach, Bioresearch Grant, Comprehensive Cancer Center

Minnesota Research Shows Potency of Kava Against Lung Cancer

Posted by Sam Asher on Fri, Apr 08, 2016

Study Shows Chemopreventative Potential of Kava-Derived Compound

"ALCOHOL IS SO 2014. TRY KAVA!

suggests a sandwich board on Tenth Street between First Avenue and Avenue A, in the East Village.

Sometimes, the most simple and elegant solution to a problem has already been known for centuries. In 2014, University of Minnesota researchers explored the medicinal capacity of an ancient plant -  Piper methysticum, c ommonly known as kava. However, concerns about kava being toxic to the liver have resulted in diminished use. Now, a recently published study has found that a specific kava derivative may have potential to combat cancer without causing any damage to liver cells.
 
 

More Research and Cancer articles:

Read More

Tags: Midwest, University of Minnesota, cancer research, Minnesota, University of Minnesota Twin Cities, Cancer, BioResearch Product Faire Event, Minneapolis, MN, UMinn, 2016, lung cancer

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News

Subscribe to this blog!